Coastwise Health Blog

Clinical Ketamine Therapy vs. At-Home Ketamine: What the FDA Said and Why It Matters

Updated May 23, 2026

← Back to Blog

Written by the Coastwise Clinical Team

In the last few years, several telemedicine companies have started prescribing ketamine through the mail. You meet briefly with a provider over video, get a prescription, and a compounding pharmacy ships ketamine lozenges to your door. You take them at home, often alone, and report back through an app.

The marketing pitch is convenience and access. The clinical reality, according to the FDA, is more complicated. Ketamine in a structured clinical setting has 25-plus years of research behind it. Ketamine taken at home, without preparation, integration, or medical oversight, is a different thing, and the risks are starting to show up in the case reports.

What's missing without clinical structure

The therapeutic value of ketamine therapy doesn't come from the molecule alone. It comes from the molecule combined with three structural elements: preparation, in-session support, and integration.

Preparation. Before a dosing session, a trained therapist works with you to set intentions, prepare your nervous system, and frame what you're working on. This typically takes one to several sessions before the first dose. Without preparation, the dosing experience is more disorganized and less productive. People who skip prep and go straight to dosing often describe sessions as "weird but unhelpful," which is exactly the problem: the medication did what it does, but nothing got built around it.

In-session support. A therapist or trained guide is present during the active dosing window. They support emotional safety, help you stay with difficult material as it surfaces, and prevent the experience from becoming destabilizing. With at-home ketamine, you're typically alone or at best on a video call with a coach you can barely interact with at peak dose. The people best positioned to help you when something hard surfaces are not in the room.

Integration. After the session, you work with your therapist to make sense of what came up, how it relates to your life patterns, and how to translate insights into actual behavior change. Without integration, the experience is just an experience. Real change rarely happens.

The KAP outcomes research (see Ketamine Therapy Research) is built on protocols that include all three elements. Removing the structure doesn't just remove the therapy. It changes what the medication does.

What the FDA said

In October 2023, the FDA issued a formal public warning about compounded ketamine, including oral and sublingual formulations, prescribed via telemedicine for psychiatric conditions. The warning specifically cited:

  • Ketamine has not been FDA-approved as safe and effective for psychiatric conditions outside the certified Spravato (esketamine) program
  • Compounded ketamine prescribed for at-home use does not have the safety oversight that applies to FDA-approved drugs
  • The FDA had received reports of adverse events from at-home use, including respiratory depression, urinary tract symptoms (ketamine bladder syndrome), and cardiovascular events
  • The agency recommended that ketamine for psychiatric use be administered with appropriate clinical monitoring

The American Medical Association issued similar concerns in parallel guidance on telemedicine prescribing of ketamine.

Specific safety concerns at home

Cardiovascular events. Ketamine raises blood pressure and heart rate. In clinical settings, vitals are monitored. At home, they're not. People with undiagnosed cardiovascular issues can have a serious event without anyone present to recognize it.

Dissociation without support. A heavier ketamine experience involves deep dissociation. In clinical KAP, a therapist is in the room to support emotional safety. At home, alone, dissociation can become disorganizing or even traumatizing, which can ironically worsen the underlying issue ketamine was supposed to help.

Ketamine bladder syndrome. Chronic high-dose ketamine use can cause severe and sometimes irreversible bladder damage. Clinical protocols dose at therapeutic levels under medical oversight. At-home users can escalate without supervision and don't always recognize the warning signs in time.

Misuse and escalation. Ketamine has abuse potential, especially when self-administered. Clinical settings dose specific quantities for specific sessions. Mail-order ketamine sitting in a kitchen drawer is much easier to escalate, especially under emotional distress, which is the same state that brought someone to ketamine in the first place.

Drug interactions. Several common medications interact with ketamine. Benzodiazepines blunt the antidepressant effect. Some blood pressure medications change the cardiovascular response. Lamotrigine can blunt the dissociative experience. A clinical team manages this. A telemedicine app often doesn't.

What clinical KAP actually includes

A clinical KAP protocol looks like this:

Intake assessment. A clinical team, therapist plus medical provider, reviews medical history, current medications, mental health history, and goals. Contraindications are screened for.

Preparation sessions. One to several therapy sessions before the first dose, building rapport, clarifying intentions, and addressing concerns.

Dosing sessions. Each session includes a pre-session check-in, the active dosing window, and immediate post-session debrief. A therapist is present throughout. A medical provider oversees the medication.

Integration sessions. Therapy sessions between dosing days, working through what came up and translating it into behavior change.

Most protocols involve 4 to 6 dosing sessions paired with integration therapy. Length and pace adjust based on response.

What Coastwise's KAP looks like

At Coastwise, our KAP program follows a structured protocol with all three elements: preparation, in-session support, and integration. Specifically:

  • Intake assessment by a licensed therapist plus medical provider review
  • Preparation phase before first dose, typically one to two sessions
  • Dosing sessions with a therapist physically present throughout
  • Sublingual lozenge or intramuscular injection depending on clinical needs (see Ketamine Therapy Types)
  • Integration sessions between dosing days
  • Minimum recommended course of 4 to 6 sessions

Our clinical team coordinates medications, monitors vitals where indicated, and adjusts the protocol based on how each client is responding.

Six questions to vet any ketamine practice

If you're considering ketamine therapy, these questions help separate a real clinical KAP practice from a prescription-only setup:

  1. Is there a preparation phase before the first dose? If you can sign up and dose within a week, that's a flag.
  2. Is a therapist physically present during the dosing session? If you're alone in a room, or alone at home, that's a flag.
  3. Is there an integration component? If there's no follow-up therapy planned, that's a flag.
  4. Does a medical provider review your medications and medical history? If a 15-minute video consult is the entire medical evaluation, that's a flag.
  5. Are vitals monitored where indicated?
  6. Does the practice screen for contraindications? History of psychosis, certain cardiovascular conditions, and other factors are reasons to not use ketamine. A real practice will tell you if you're not a fit.

Insurance

Therapy sessions in clinical KAP are covered by most major insurance plans. The medication itself is often out of pocket. At-home telemedicine ketamine services are typically fully out of pocket and rarely covered. Spravato (FDA-approved esketamine) is covered with prior authorization for treatment-resistant depression. Our admissions team verifies what your specific plan covers. Call (424) 536-3002 or verify your insurance online.

Considering KAP?

If you're trying to decide between an at-home service and a clinical KAP program, the six questions above are a useful starting point. You can also call us for a free consultation. We'll talk you through how clinical KAP works, what we offer, what we don't, and whether it fits your situation. If your clinical picture calls for IV infusion, which we don't offer on-site, we'll point you to a partner.

Call (424) 536-3002 or request a consultation online. Monday through Saturday, 9:00 AM to 8:00 PM.

Located at 1366 W 7th Street, San Pedro, CA.

Frequently Asked Questions

The FDA issued a public warning in October 2023 about compounded ketamine prescribed via telemedicine for psychiatric use, citing reports of cardiovascular events, urinary tract symptoms, respiratory depression, and other adverse events. Ketamine in a clinical setting with medical oversight has a well-established safety profile. At-home ketamine without preparation, in-session support, or integration removes most of the safety structure that makes the medication work well in research settings.

The therapeutic effect of ketamine-assisted psychotherapy comes from the medication paired with three structural elements: preparation before the first dose, an in-session therapist or guide during the dosing window, and integration sessions afterward. The KAP outcomes research is built on protocols that include all three. Removing the structure doesn't just remove the therapy. It changes what the medication does.

In October 2023, the FDA issued a formal public warning about compounded ketamine prescribed via telemedicine for psychiatric conditions. The warning highlighted that ketamine is not FDA-approved for psychiatric use outside the Spravato (esketamine) program, that compounded ketamine doesn't have FDA safety oversight, and that the agency had received reports of adverse events from at-home use including cardiovascular events and ketamine bladder syndrome.

Ketamine raises blood pressure and heart rate, which in clinical settings is monitored but at home is not. Heavy ketamine use can cause severe bladder damage (ketamine bladder syndrome). Dissociative experiences without an in-session therapist can become destabilizing. Ketamine has abuse potential and is easier to escalate when self-administered. Some common medications (benzodiazepines, certain blood pressure medications) interact with ketamine in ways a telemedicine app often doesn't manage.

Coastwise's ketamine-assisted psychotherapy includes preparation sessions before the first dose, a therapist physically present during each dosing session, integration therapy between sessions, medical provider oversight, and a structured course of treatment (typically 4 to 6 sessions). The cost per session is higher than mail-order services, but the clinical structure is what produces the outcomes the research describes.

Look for a preparation phase before the first dose, a therapist physically present during dosing, integration sessions afterward, medical provider review of your medications and medical history, vitals monitoring where indicated, and clear screening for contraindications like history of psychosis or specific cardiovascular conditions. If a service can't answer those questions clearly, it's not delivering KAP in a meaningful clinical sense.

References and Further Reading

  • U.S. Food and Drug Administration. "FDA warns patients and health care providers about potential risks associated with compounded ketamine, including oral formulations, for the treatment of psychiatric disorders." October 10, 2023. fda.gov
  • American Medical Association. "Online prescribing of ketamine: Questions arise about tele-mental health." ama-assn.org
  • Krystal JH, Abdallah CG, Sanacora G, Charney DS, Duman RS. "Ketamine: A Paradigm Shift for Depression Research and Treatment." Neuron. 2019;101(5):774-778. PubMed: 30844397
  • Wilkinson ST, Toprak M, Turner MS, Levine SP, Katz RB, Sanacora G. "A Survey of the Clinical, Off-Label Use of Ketamine as a Treatment for Psychiatric Disorders." American Journal of Psychiatry. 2017;174(7):695-696. PubMed: 28669202
  • Dore J, Turnipseed B, Dwyer S, et al. "Ketamine Assisted Psychotherapy (KAP): Patient Demographics, Clinical Data and Outcomes in Three Large Practices Administering Ketamine with Psychotherapy." Journal of Psychoactive Drugs. 2019;51(2):189-198. PubMed: 30917760
  • Schak KM, Vande Voort JL, Johnson EK, et al. "Potential Risks of Poorly Monitored Ketamine Use in Depression Treatment." American Journal of Psychiatry. 2016;173(3):215-218. PubMed: 26926127

Related Articles

Types of Ketamine Therapy

Read more →

Ketamine Therapy Research

Read more →

Coastwise KAP Program

Read more →

Considering Ketamine Therapy?

The first call is free, confidential, and without pressure. We'll help you figure out whether KAP fits, and if not, we'll point you somewhere that does.

Call (424) 536-3002 Get Started Online
Call (424) 536-3002